SYRA icon

Syra Health

0.2699 USD
+0.0100
3.85%
At close Apr 1, 4:00 PM EDT
1 day
3.85%
5 days
-11.57%
1 month
-29.68%
3 months
-38.62%
6 months
-28.95%
Year to date
-38.62%
1 year
-81.13%
5 years
-91.00%
10 years
-91.00%
0
Funds holding %
of 7,398 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

0% more funds holding

Funds holding: 13 [Q3] → 13 (+0) [Q4]

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

1.65% less ownership

Funds ownership: 7.87% [Q3] → 6.21% (-1.65%) [Q4]

24% less capital invested

Capital invested by funds: $299K [Q3] → $228K (-$70.8K) [Q4]

Research analyst outlook

We haven’t received any recent analyst ratings for SYRA.

Financial journalist opinion

Based on 4 articles about SYRA published over the past 30 days

Neutral
PRNewsWire
2 weeks ago
Syra Health Secures $660,000 Population Health Contract Extension
CARMEL, Ind. , March 13, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today a one-year, $660,000 Population Health contract extension with a national healthcare organization.
Syra Health Secures $660,000 Population Health Contract Extension
Neutral
Seeking Alpha
3 weeks ago
Syra Health Corp. (SYRA) Q4 2024 Earnings Call Transcript
Syra Health Corp. (NASDAQ:SYRA ) Q4 2024 Earnings Call March 11, 2025 9:00 AM ET Company Participants Brett Maas - Investor Relations Deepika Vuppalanchi - Chair and Chief Executive Officer Priya Prasad - Chief Financial Officer Brett Maas Good morning, everyone, and thank you for joining us for Syra Health's Fourth Quarter and Full Year 2024 Financial Results Conference Call. My name is Brett Maas of Hayden IR, and I direct Investor Relations for Syra Health.
Syra Health Corp. (SYRA) Q4 2024 Earnings Call Transcript
Neutral
PRNewsWire
3 weeks ago
Syra Health Announces Full-Year Revenue of $8.0 Million, Up 45% YoY
2024 Population Health Revenue Acceleration to 132% YoY Q4 2024 Net Losses Cut Nearly in Half Compared to Q4 2023, Highlighting Major Efficiency Gains Continued Momentum with New Customer Wins and Contract Extensions Driving Sustainable Growth A conference call will be held today, Tuesday, March 11 at 9:00 am ET CARMEL, Ind. , March 11, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for fourth quarter and full year ended December 31, 2024.
Syra Health Announces Full-Year Revenue of $8.0 Million, Up 45% YoY
Neutral
PRNewsWire
4 weeks ago
Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results
Conference call will be held on Tuesday, March 11 at 9:00 a.m. ET CARMEL, Ind.
Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results
Neutral
PRNewsWire
1 month ago
Syra Health Secures Population Health Contract Extension in Shelby County, Tennessee
CARMEL, Ind. , Feb. 25, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today a $450,000 contract extension with the Shelby County Health Department in Tennessee.
Syra Health Secures Population Health Contract Extension in Shelby County, Tennessee
Neutral
PRNewsWire
1 month ago
Syra Health Announces Positive Preliminary Results from Syrenity Study Led by Indiana University
CARMEL, Ind. , Feb. 18, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today positive preliminary results from the clinical research study being conducted by Indiana University (IU) of its flagship mental health product, Syrenity.
Syra Health Announces Positive Preliminary Results from Syrenity Study Led by Indiana University
Neutral
PRNewsWire
1 month ago
Syra Health Continues to Secure Healthcare Training Contracts
CARMEL, Ind. , Feb. 13, 2025 /PRNewswire/ -- Syra Health Corp. (Nasdaq: SYRA), a healthcare technology company powering better health by providing meaningful solutions, announced today that it has been awarded a six-month, $135,000 contract with a Midwest-based university to develop prevention-focused virtual training modules in behavioral health.
Syra Health Continues to Secure Healthcare Training Contracts
Neutral
PRNewsWire
2 months ago
Syra Health Wins New Workforce Contract, Announces Existing Contract Extension
CARMEL, Ind. , Jan. 7, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that the Washington D.C.
Syra Health Wins New Workforce Contract, Announces Existing Contract Extension
Neutral
PRNewsWire
3 months ago
Syra Health Launches Syrenity: An Evidence-Based App for Managing Common Mental Health Conditions
- Now Available for Download on the  App Store and Google Play Store. CARMEL, Ind.
Syra Health Launches Syrenity: An Evidence-Based App for Managing Common Mental Health Conditions
Neutral
PRNewsWire
4 months ago
Syra Health to Present at NobleCon20
CARMEL, Ind. , Nov. 26, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today its participation in the Noble Financial Capital Markets 20th Annual Equity Conference, known as NobleCon20, taking place December 3-4 in Boca Raton, Florida.
Syra Health to Present at NobleCon20
Charts implemented using Lightweight Charts™